Medical Tourism: Ensuring UK Patient Safety in the Global Medical Tourism Industry

Authors: Michael Ilsemann, Dr Iseult Roche, Dr Paul Charlson

Healthcare is no longer confined by national borders. Advances in travel, digital technology and global investment have made it easier than ever for UK citizens to access treatment abroad. What was once a niche practice is now a rapidly expanding global industry.

Outward medical tourism is driven by affordability, shorter waiting times, wider treatment availability and a desire for greater patient choice. For many, travelling overseas represents faster access to procedures or medicines that may be delayed, restricted or more costly in the UK.

However, opportunity is accompanied by risk. Variations in regulatory standards, pre-operative screening, aftercare and legal protection can expose patients to serious harm. When complications arise, responsibility often falls to the NHS, creating wider implications for UK healthcare.

As Michael Ilsemann notes:

“Medical tourism is a rational response to cost, waiting times and limited choice. The role of policymakers is not to condemn it, but to ensure UK patients are protected wherever they seek care.”

This White Paper examines the evidence, risks and policy reforms needed to safeguard UK patients in an increasingly global healthcare market.